pentobarbital will reduce the level or result of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Solid CYP3A4 inducers may possibly minimize partiaprevir and ritonavir stages, and for that reason lowered efficacy of Viekira Pakpentobarbital will lessen the extent or impa